ORBIMED ADVISORS LLC: NPCE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on NPCE, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 1,055,125 NPCE shares at 2026-09-30 per its 13F-HR filed 2026-11-16.
the latest 13F is the newest step
- period ended2026-09-3013F 1,055,125 sharesChange vs previous 13F -450,000 shares
0.27% of the 13F portfolio, value $14,518,520.
13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
Accepted , ingested - period ended2026-06-3013F 1,505,125 sharesChange vs previous 13F -591,402 shares
0.45% of the 13F portfolio, value $23,916,436.
13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,096,527 sharesChange vs previous 13F -309,808 shares
0.6% of the 13F portfolio, value $27,569,330.
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,406,335 sharesChange vs previous 13F -207,849 shares
0.76% of the 13F portfolio, value $37,153,812.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,614,184 sharesChange vs previous 13F 0 shares
0.65% of the 13F portfolio, value $26,952,237.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,614,184 sharesChange vs previous 13F -792,151 shares
0.73% of the 13F portfolio, value $29,122,010.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,406,335 sharesChange vs previous 13F 0 shares
1.01% of the 13F portfolio, value $41,863,857.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 3,406,335 sharesChange vs previous 13F not available
0.79% of the 13F portfolio, value $38,116,889.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).